269 studies found for:    Open Studies | "Parasitic Diseases"
Show Display Options
Rank Status Study
21 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
22 Recruiting Taenia Solium Control Case Study in Zambia
Conditions: Cysticercosis;   Helminthiasis
Intervention: Behavioral: CLTS
23 Not yet recruiting Single Ascending Dose Safety Study of Oxfendazole
Condition: Tenia Solium Infection
Interventions: Drug: oxfendazole;   Drug: placebo
24 Not yet recruiting Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
Condition: Neurocysticercosis
Interventions: Drug: Oxfendazole;   Drug: Placebo
25 Recruiting Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
26 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
27 Unknown  Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
Conditions: Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: Peginterferon Alfa-2a plus Ribavirin
28 Unknown  Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
Condition: Malaria
Intervention: Drug: Fosmidomycin and clindamycin
29 Not yet recruiting A Prospective, Phase II Clinical Trial for Evaluation of G- CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy
Condition: Chronic Chagasic Myocarditis
Interventions: Drug: Treatment with G-CSF (Granulocyte colony stimulating factor);   Drug: Placebo saline
30 Recruiting Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults
Condition: Malaria
Interventions: Biological: FMP012 with AS01B adjuvant system;   Other: P falciparum Controlled Human Malaria Infection (CHMI)
31 Recruiting Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg
Condition: Acute Uncomplicated Falciparum Malaria
Interventions: Drug: COA566;   Drug: Artemether-lumefantrine dispersible tablet
32 Unknown  A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan
Conditions: Uncomplicated Falciparum Malaria;   Vivax Malaria
Interventions: Drug: Dihydroartemisinin + Piperaquine (Artekin);   Drug: artesunate-sulphadoxin/pyrimethamine, chloroquine
33 Recruiting Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
Condition: Malaria
Intervention:
34 Recruiting Study to Assess the Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects
Condition: Malaria
Interventions: Drug: ACT-451840;   Other: Plasmodium falciparum-infected human erythrocytes;   Drug: Artemether 20 mg and lumefantrine 120mg combination tablet;   Drug: Primaquine
35 Unknown  Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana
Condition: Anemia
Interventions: Dietary Supplement: Sprinkles®;   Dietary Supplement: vitamin/mineral fortificant without iron
36 Unknown  Phase III, Study of Three Short Course Combination Regimens (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome® Alone for the Treatment of Visceral Leishmaniasis in Bangladesh
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B;   Drug: liposomal amphotericin B + miltefosine;   Drug: liposomal amphotericin B + paromomycin;   Drug: Miltefosine + Paromomycin
37 Unknown  Parasite-based Diagnosis for Malaria in Uganda: Feasibility and Cost-Effectiveness
Conditions: Fever;   Malaria
Intervention: Device: Field microscopy and Paracheck Pf®
38 Unknown  Pharmacokinetics and Pharmacodynamics of Intravenous Artesunate for Severe Malaria Treatment
Condition: Severe Malaria
Intervention: Drug: intravenous artesunate
39 Unknown  Contrast-Enhanced US of Spleen, Liver and Kidney
Conditions: Malaria;   Pyelonephritis;   Bacterial Infections
Intervention:
40 Recruiting Improving Blood Safety and HIV Testing in Brazil
Conditions: HIV;   Herpes Simplex 2;   Hepatitis C;   Hepatitis B;   Chagas Disease
Interventions: Behavioral: HIV Counseling and Testing;   Behavioral: Blood Donation

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years